Administration of nattokinase was shown to inhibit the expression of transcription factors CD31, FOXM1, CD44, and vimentin that regulate tumor proliferation, survival, and drug resistance in a mouse model of liver cancer, thereby reducing the tumor growth rate [11]. The gene discussed is CD44; the disease is neoplasm.